Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter.
Most medical societies urge their clinical-guidance developers to include cost data alongside care recommendations. Yet less than a quarter of published advisements—22.5%—contain evidence-based discussions on economic considerations or resource consumption.
The health network, which operates 37 hospitals in California, drastically reduced scheduling delays after integrating an FDA-cleared algorithm designed to speed up imaging acquisition times.
A report from Trilliant Health looking at payer data found that, as prescriptions for the popular weight loss drugs spike, so rises the number of approved benefits.
Fears about the risk of sudden cardiac arrest are being used to order unnecessary electrocardiogram and echocardiograms for young athletes, according to a new warning from multiple federal agencies.
Eli Lilly and Company is back with even more positive data on orforglipron, its oral GLP-1 receptor agonist. The company says it is "moving with urgency" toward gaining key regulatory approvals and getting the drug in the hands of patients.
"Today’s sentence sends a deterrent message to doctors and the healthcare industry," according to a DOJ statement. "If you abuse patient trust for profit, you will face justice."
Placenta accreta spectrum is a serious and sometimes deadly perinatal complication. Instances of the condition have risen in recent decades, potentially due to an increase in cesarean deliveries.
Radiologist Henry C. Lusane, MD, with Acumen Medical Imaging, interpreted the scans, reporting the mass as benign, a mistake later leading to a terminal cancer diagnosis.
The Women’s Center for Radiology, which was acquired by Solis Mammography in January, hired a cybersecurity firm to help investigate the scope of the matter.
Most medical societies urge their clinical-guidance developers to include cost data alongside care recommendations. Yet less than a quarter of published advisements—22.5%—contain evidence-based discussions on economic considerations or resource consumption.
